首页> 外文OA文献 >Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

【2h】

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

机译：基于LINAC的立体定向放疗后的听力损失的进展与门诊剂量有关，没有预处理听力水平

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. van Linge; R. van Os; N. Hoekstra; B. Heijmen; L. Stienstra; A. Dallenga; J. Wolbers; A. Mendez Romero;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma [J] . Kunal S. Patel, Edwin Ng, Taranjit Kaur, Journal of neuro-oncology. . 2019,第2期

机译：增加的耳蜗辐射剂量预测前定向放射外科和分级施瓦新瘤的分级定向术和分级立体定向放疗后的延迟听力损失
2. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. [J] . Thomas C, Di-Maio S, Ma R, Journal of neurosurgery. . 2007,第5期

机译：分形立体定向放射疗法治疗前庭神经鞘瘤后的听力保存：耳蜗剂量的预后意义。
3. Medication for hearing loss after fractionated stereotactic radiotherapy (SRT) for vestibular schwannoma. [J] . Sakamoto T, Shirato H, Takeichi N, International Journal of Radiation Oncology, Biology, Physics . 2001,第5期

机译：前庭神经鞘瘤的分级立体定向放射治疗（SRT）后用于听力损失的药物。
4. Long-Term Follow-up Results with Audiological Assessment After Fractionated Stereotactic Radiotherapy for Vestibular Schwannomas [C] . Yutaka Sawamura, Hiroki Shirato, Touru Sakamoto, Keio International Symposium for Life Sciences and Medicine . 2003

机译：随机学评估的长期随访结果分级后分级的立体定向放疗前庭施韦马斯
5. Asymmetric hearing loss stratification and vestibular schwannoma risk: A meta-analysis [D] . Egan, Cameron R. 2015

机译：不对称听力损失分层和前庭施瓦新瘤风险：荟萃分析
6. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose not with pre-treatment hearing level [O] . A. van Linge, R. van Os, N. Hoekstra, 2018

机译：基于LINAC的前庭神经鞘瘤的立体定向放射治疗后听力丧失的进展与耳蜗剂量有关与治疗前的听力水平无关
7. Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma [O] . Lawrance Chung, Nolan Ung, John Sheppard, 2017

机译：耳蜗剂剂量对静态放射前肠外放射牢房和分级立体定向放射治疗治疗前庭施瓦南瘤的影响

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

著录项

引文网络

相似文献

相关主题

期刊订阅